Regulatory News In Brief
This article was originally published in The Gray Sheet
Executive Summary
CDRH pursuing workplace fixes
You may also be interested in...
FDA Glass Syringe Guidance Aims To Solve Connectivity Problems
Following a series of adverse events, an FDA draft guidance on glass syringes recommends supplemental tests to ensure device safety and effectiveness.
BD Makes Pharma Debut With Generic Prefilled Syringe
BD gained FDA approval for the first in a line of prefilled generic injectable drugs that will be marketed by its new subsidiary, BD Rx.
FDA's Device Center Faces New Charge Of Whistleblower Retaliation
Federal officials took steps last week to reinstate a recently fired reviewer in FDA's diagnostics office, claiming that agency actions may have violated the Whistleblower Protection Act.